![]() AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ![]() ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market. | ![]() BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. | |
Founding Date | Founding Date 1999 | Founding Date N/A | Founding Date 2010 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations SG HQ Collingwood, AU | Locations Florham Park, US HQ |
Employees | Employees 94,300 | Employees 35 | Employees 4014% increase |
Valuation ($) | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) 89.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $4.9b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $54.2b (FY, 2025) | Gross profit $12m (FY, 2023) | Gross profit N/A |
Net income | Net income $10.2b (FY, 2025) | Net income ($44.2m) (FY, 2023) | Net income ($16.7m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 1b | Total funding raised $ 100m | Total funding raised $ 36.1m |

ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
View company
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
View company